Efficacy and safety of abiraterone acetate plus prednisolone in patients with early metastatic castration-resistant prostate cancer who failed first-line androgen-deprivation therapy: a single-arm, phase 4 study

AIM: The aim was to evaluate the efficacy and safety of abiraterone acetate plus prednisolone in patients with chemotherapy-naïve early metastatic castration-resistant prostate cancer who failed first-line androgen deprivation therapy. METHODS: Patients with early metastatic castration-resistant pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, K, Okuno, N, Arai, G, Nakatsu, H, Maniwa, A, Kamiya, N, Satoh, T, Kikukawa, H, Nasu, Y, Uemura, H, Nakashima, T, Mikami, K, Iinuma, M, Tanabe, K, Furukawa, J, Kobayashi, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012350/
https://www.ncbi.nlm.nih.gov/pubmed/33324967
http://dx.doi.org/10.1093/jjco/hyaa225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012350/
https://www.ncbi.nlm.nih.gov/pubmed/33324967
http://dx.doi.org/10.1093/jjco/hyaa225

Ejemplares similares